Key role of the GITR/GITRLigand pathway in the development of murine autoimmune diabetes: a potential therapeutic target.

Key role of the GITR/GITRLigand pathway in the development of murine autoimmune diabetes: a potential therapeutic target.

BACKGROUND: The cross-talk between pathogenic T lymphocytes and regulatory T cells (Tregs) plays a major role in the progression of autoimmune diseases. Our objective is to identify molecules and/or pathways involved in this interaction and representing potential targets for innovative therapies. Gl...

Full description

Bibliographic Details
Main Authors:	You, S, Poulton, L, Cobbold, S, Liu, C, Rosenzweig, M, Ringler, D, Lee, W, Segovia, B, Bach, J, Waldmann, H, Chatenoud, L
Format:	Journal article
Language:	English
Published:	2009

Similar Items

Key role of the GITR/GITRLigand pathway in the development of murine autoimmune diabetes: a potential therapeutic target.
by: Sylvaine You, et al.
Published: (2009-11-01)

In vivo kinetics of GITR, GITR-L expression and their functional significance in regulating viral immunopathology
by: Suvas, S, et al.
Published: (2005)

The Role of GITR/GITRL Interaction in Autoimmune Diseases
by: Jie Tian, et al.
Published: (2020-10-01)

In vivo kinetics of GITR and GITR ligand expression and their functional significance in regulating viral immunopathology.
by: Suvas, S, et al.
Published: (2005)

Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells.
by: You, S, et al.
Published: (2005)

CD4+ T cell fate decisions are stochastic, precede cell division, depend on GITR co-stimulation, and are associated with uropodium development
by: Cobbold, SP, et al.
Published: (2018)

CD4+ T Cell Fate Decisions Are Stochastic, Precede Cell Division, Depend on GITR Co-Stimulation, and Are Associated With Uropodium Development
by: Stephen P. Cobbold, et al.
Published: (2018-06-01)

Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas
by: Amoozgar, Zohreh, et al.
Published: (2022)

Structural basis for ligand-mediated mouse GITR activation.
by: Zhou, Z, et al.
Published: (2008)

INSITU ANALYSIS OF THYROID T-CELL INFILTRATES IN MURINE EXPERIMENTAL AUTOIMMUNE-THYROIDITIS (EAT)
by: Conaway, D, et al.
Published: (1987)

Murine B cell development and antibody responses to model antigens are not impaired in the absence of the TNF receptor GITR.
by: Lenka Sinik Teodorovic, et al.
Published: (2012-01-01)

Depletion of CD4+ and CD8+ cells eliminates immunologic memory of thyroiditogenicity in murine experimental autoimmune thyroiditis.
by: Fuller, B, et al.
Published: (1994)

Pathogenic mechanisms in murine autoimmune thyroiditis: short- and long-term effects of in vivo depletion of CD4+ and CD8+ cells.
by: Kong, Y, et al.
Published: (1989)

Suppression in murine experimental autoimmune thyroiditis: in vivo inhibition of CD4+ T cell-mediated resistance by a nondepleting rat CD4 monoclonal antibody.
by: Nabozny, G, et al.
Published: (1991)

MS4A4B is a GITR-associated membrane adapter, expressed by regulatory T cells, which modulates T cell activation.
by: Howie, D, et al.
Published: (2009)

Blocking the GITR-GITRL pathway to overcome resistance to therapy in sarcomatoid malignant pleural mesothelioma
by: Meilin Chan, et al.
Published: (2021-07-01)

Monoclonal antibodies as agents to reinduce tolerance in autoimmunity.
by: Waldmann, H, et al.
Published: (1992)

Agonist anti-GITR antibody significantly enhances the therapeutic efficacy of Listeria monocytogenes-based immunotherapy
by: Rajeev Shrimali, et al.
Published: (2017-08-01)

Gene expression in the Gitr locus is regulated by NF-κB and Foxp3 through an enhancer.
by: Tone, Y, et al.
Published: (2014)

Therapeutic use of a selective S1P1 receptor modulator ponesimod in autoimmune diabetes.
by: Sylvaine You, et al.
Published: (2013-01-01)

Ubiquitination role in TCR signaling and costimulation via GITR
by: Muller, J, et al.
Published: (2016)

New emerging targets in cancer immunotherapy: the role of GITR
by: Chiara Dellepiane, et al.
Published: (2019-06-01)

Reprogramming the immune system: a possible therapeutic approach to established autoimmune disease.
by: Waldmann, H, et al.
Published: (1993)

Expression of GITR Enhances Multiple Myeloma Cell Sensitivity to Bortezomib.
by: Yinghao Zhao, et al.
Published: (2015-01-01)

Glucocorticoid induced TNFR-related protein (GITR) as marker of human regulatory T cells: expansion of the GITR+CD25- cell subset in patients with systemic lupus erythematosus
by: E. Bartoloni Bocci, et al.
Published: (2011-06-01)

Future therapeutics for the induction of peripheral immune tolerance in autoimmune disease and organ transplantation.
by: Cobbold, S
Published: (2009)

Therapeutic potential of monovalent monoclonal antibodies.
by: Cobbold, S, et al.
Published: (1984)

Resistance of regulatory T cells to glucocorticoid-induced [corrected] TNFR family-related protein (GITR) during Plasmodium yoelii infection.
by: Hisaeda, H, et al.
Published: (2005)

Corrigendum: Therapeutic potential of monovalent monoclonal antibodies
by: Cobbold, S, et al.
Published: (1984)

GITR Activation Positively Regulates Immune Responses against Toxoplasma gondii.
by: Frederico R C Costa, et al.
Published: (2016-01-01)

A THEORETICAL FRAMEWORK FOR SELF-TOLERANCE AND ITS RELEVANCE TO THERAPY OF AUTOIMMUNE-DISEASE
by: Waldmann, H, et al.
Published: (1988)

Monoclonal antibodies for the therapeutic induction of tolerance.
by: Waldmann, H, et al.
Published: (1993)

Quantitative systems pharmacology model of GITR‐mediated T cell dynamics in tumor microenvironment
by: Yan Ji, et al.
Published: (2023-03-01)

GITR Promotes the Polarization of TFH-Like Cells in Helicobacter pylori-Positive Gastritis
by: Siqi Ming, et al.
Published: (2021-09-01)

Tolerance induction by monoclonal CD3 antibodies is dependent on indoleamine 2,3 dioxygenase (IDO)
by: Kuhn, C, et al.
Published: (2012)

Induction of immunological tolerance as a therapeutic procedure
by: Waldmann, H, et al.
Published: (2016)

GITR and TIGIT immunotherapy provokes divergent multicellular responses in the tumor microenvironment of gastrointestinal cancers
by: Anuja Sathe, et al.
Published: (2023-11-01)

Cyclophosphamide enhances the antitumor potency of GITR engagement by increasing oligoclonal cytotoxic T cell fitness
by: Daniel Hirschhorn, et al.
Published: (2021-10-01)

Novel tumor suppressor function of glucocorticoid-induced TNF receptor GITR in multiple myeloma.
by: Yang Liu, et al.
Published: (2013-01-01)

Atypical TNF-TNFR superfamily binding interface in the GITR-GITRL complex for T cell activation
by: Min Zhao, et al.
Published: (2021-09-01)